We are getting near the pointy end of research into Efti's effectiveness in assisting treatment for various cancer indications....
In combination with keytruda it is showing better results with more successful outcomes for patients than keytruda alone
in trials conducted sofar....Even signs of a combo that can negate the need for chemotherapy in certrain cases....
To be brutally honest, there is gonna need to be a major reversal in trial data over the next few months for Efti to fall over...
We have much to look forward to here and to be honest once again there is cause for confidence...
- Forums
- ASX - By Stock
- IMM
- An obsevation re Eftiligomab alfa
IMM
immutep limited
Add to My Watchlist
4.17%
!
23.0¢

An obsevation re Eftiligomab alfa
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
23.0¢ |
Change
-0.010(4.17%) |
Mkt cap ! $337.6M |
Open | High | Low | Value | Volume |
24.0¢ | 24.0¢ | 23.0¢ | $244.5K | 1.043M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
20 | 392012 | 23.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.5¢ | 126850 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
20 | 392012 | 0.230 |
28 | 955468 | 0.225 |
19 | 589222 | 0.220 |
6 | 96683 | 0.215 |
5 | 35289 | 0.210 |
Price($) | Vol. | No. |
---|---|---|
0.235 | 126850 | 6 |
0.240 | 371049 | 7 |
0.245 | 240928 | 6 |
0.250 | 44180 | 3 |
0.255 | 92100 | 4 |
Last trade - 16.10pm 12/09/2025 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |